1. Home
  2. SEM vs MNKD Comparison

SEM vs MNKD Comparison

Compare SEM & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Select Medical Holdings Corporation

SEM

Select Medical Holdings Corporation

HOLD

Current Price

$16.38

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$5.66

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEM
MNKD
Founded
1996
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.8B
IPO Year
2009
2004

Fundamental Metrics

Financial Performance
Metric
SEM
MNKD
Price
$16.38
$5.66
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$16.33
$10.08
AVG Volume (30 Days)
708.7K
3.8M
Earning Date
02-19-2026
02-23-2026
Dividend Yield
1.53%
N/A
EPS Growth
N/A
23.47
EPS
0.87
0.10
Revenue
$5,368,760,000.00
$313,787,000.00
Revenue This Year
$5.53
$21.29
Revenue Next Year
$4.33
$25.53
P/E Ratio
$21.56
$57.82
Revenue Growth
45.29
17.43
52 Week Low
$11.65
$3.38
52 Week High
$19.54
$6.51

Technical Indicators

Market Signals
Indicator
SEM
MNKD
Relative Strength Index (RSI) 76.45 48.15
Support Level $14.96 $5.54
Resistance Level $15.73 $6.05
Average True Range (ATR) 0.31 0.29
MACD 0.12 -0.01
Stochastic Oscillator 92.11 28.24

Price Performance

Historical Comparison
SEM
MNKD

About SEM Select Medical Holdings Corporation

Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: